Upfront Therapy for ITP in Children: New Drug a Game-Changer?December 17, 2024Bleeding DisordersThrombosisPediatricsASH 2024
Do GLP-1s Lower VTE Risk in People With Type 2 Diabetes?December 12, 2024ThrombosisMixed TopicsASH 2024
Rilzabrutinib Shines in Phase 3 Trial of Tough-to-Treat Immune ThrombocytopeniaDecember 10, 2024Bleeding DisordersThrombosisASH 2024
ASH 2024: New Leukemia Txs, Fewer Blood Clots With GLP-1 RxsDecember 9, 2024ALLCLLBleeding DisordersThrombosis
On Second Thought: Aspirin for Primary Prevention — What We Really KnowNovember 6, 2024Mixed TopicsThrombosis
No Routine Cancer Screening Option? New MCED Tests May HelpApril 15, 2024Patient & Survivor CareDLBCLAggressive LymphomasALLAMLB Cell LymphomaCLL
FDA OKs Danicopan Add-On for Extravascular Hemolysis in Adults With PNHApril 2, 2024Bleeding DisordersThrombosis
Hematology is in the Brodsky family’s bloodDecember 6, 2023Mixed TopicsCMLBleeding DisordersTransplantThrombosisAnemiaMyelodysplastic Syndrome
ASH 2023: Equity, Sickle Cell, and Real-Life OutcomesDecember 4, 2023Mixed TopicsBleeding DisordersAMLThrombosisTransplantMultiple MyelomaMyelodysplastic Syndrome
FDA approves first tx for rare, deadly clotting disorderNovember 13, 2023Bleeding DisordersThrombosis
Nationwide hematologists shortage: What’s being done?September 20, 2023Bleeding DisordersBusiness of MedicineMixed TopicsThrombosis
Using JAK inhibitors for myelofibrosisSeptember 11, 2023Myelodysplastic SyndromeAMLAnemiaBleeding DisordersMixed TopicsThrombosisTransfusion Medicine
CHP/CCUS: Low blood cancer risk for most patientsSeptember 8, 2023Mixed TopicsMyelodysplastic SyndromeAnemiaThrombosisPatient & Survivor CareBleeding Disorders
Medicare announces 10 drugs targeted for price cuts in 2026August 30, 2023Business of MedicinePatient & Survivor CareThrombosis
